ETF Series Solutions ETF CBOE Vest S&P 500 Divid (KNG)

$44.30 0.38 (0.85%)

20:00 EDT KNG Stock Quote Delayed 30 Minutes

Volume:

Previous Close $44.30

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 5,500

Day's Range 44.30 - 44.76

52-Week Range 30.00 - 47.39

Dividend & Yield 0.87 (1.96%)

KNG Stock Predictions, Articles, and ETF Series Solutions ETF CBOE Vest S&P 500 Divid News

From InvestorPlace
From the Web

5 Dividend Aristocrat ETFs for a Growing Retirement Income

By Will Healy, InvestorPlace Contributor Jul 6, 2018

Retirement stocks can often be limited with 401k investing, but when investing for retirement, dividend aristocrat funds can provide a healthy combination of income and growth.

European advisory group backs expanded use of Vifor Fresenius' Velphoro (NYSE:FMS)

From Seeking Alpha Sep 18, 2020

The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Vifor Fresenius Medical Care Renal Pharma's Velphoro (mixture of polynuclear iron (III)-oxyhydroxide, sucrose and starches) for the control of serum phosphorus levels in pediatric patients at least two years old with chronic kidney disease (CKD) stages 4-5 (defined by a glomerular filtration rate <30 mL/min/1.73 m²) or with CKD on dialysis.The current indication is for the control of serum phosphorus levels in adult CKD patients on hemodialysis or peritoneal dialysis.A final decision from the European Commission usually takes ~60 days.Vifor Fresenius Renal Care Pharma is jointly owned by Galencia (55%) amd Fresenius Medical Care (45%) (FMS -0.5%).

3 MedTech Outperformers to Grab Amid September Pullback

From Zacks Investment Research Sep 18, 2020

Let's grab these three stocks that have continued to show tremendous promise despite market volatility resulting from the coronavirus pandemic.

5 Top PEG-Driven Value Stocks Amid Coronavirus-Led Selloffs

From Zacks Investment Research Sep 15, 2020

While searching for a suitable value investment option, investors are unlikely to consider PEG ratio among a number of other popular value metrics.

Buy 4 Beaten-Down MedTech Value Stocks Amid September Selloffs

From Zacks Investment Research Sep 15, 2020

Here are some dirt-cheap MedTech value stocks which have been battered by the pandemic-led market meltdown and can be considered for long-term gains.

3 MedTech Outperformers To Grab Amid Coronavirus Pandemic

From Talk Markets Sep 10, 2020

The coronavirus pandemic threw a curveball that has impacted every facet of life and the MedTech industry has been no exception to the trend.

CHDN, AMC, FMS, OMI and TMO as Zacks Bull and Bear of the Day

From Zacks Investment Research Sep 11, 2020

CHDN, AMC, FMS, OMI and TMO as Zacks Bull and Bear of the Day